C

Central Coast Neurosciences Research | Erina and Tumbi Umbi

Research site
(Unclaimed)
Location
Suite 2 Level 2 Element Building 200 Central Coast Highway, Erina, New South Wales, Australia

Site insights

Top conditions

Top treatments

Donanemab
Gantenerumab
Bococizumab
LY3002813
RO4602522
Crenezumab
Pegcetacoplan
Aducanumab
BIIB037

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 10 total trials

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The study duration includ...

Enrolling
Alzheimer Disease
Mental Disorders
Drug: Placebo
Drug: Donanemab

Trial sponsors

Roche logo
Lilly logo
Pfizer logo
A
Biogen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems